This user has not added any information to their profile yet.
Select publications
Koss B, Shields BD, Taylor EM, Storey AJ, Byrum SD, Gies AJ, Washam CL, Choudhury SR, Ahn JH, Uryu H, Williams JB, Krager KJ, Ciang TC, Mackintosh SG, Edmondson RD, Aykin-Burns N, Gajewski TF, Wang G, and Tackett AJ (2020) Epigenetic control of Cdkn2a.Arf protects tumor-infiltrating lymphocytes from metabolic exhaustion. Cancer Research, 80(21): 4707-4719.
Shields BD, Koss B, Taylor EM, Storey AJ, West K, Byrum SD, Mackintosh SG, Edmondson R, Mahmoud F, SHalin SC, and Tackett AJ (2019) Loss of E-cadherin inhibits CD103 anti-tumor activity and reduces checkpoint blockade responsiveness in melanoma. Cancer Research, 79(6):1113-1123 (PMID30674537).
Shields BD, Mahmoud F, Taylor EM, Byrum SD, Sengupta D, Koss B, Baldini, G, Ransom S, Cline K, Mackintosh SG, Edmondson RD, Shalin S and Tackett AJ (2017) Indicators of responsiveness to immune checkpoint inhibitors. Nature Sci Rep, 7(1), 807 (PMC5429745).
Sengupta D, Byrum SD, Avaritt NL, Davis L, Mahmoud F, Reynolds M, Shields B, Orr LM, Mackintosh SG, Shalin SC and Tackett AJ (2016) Quantitative histone mass spectrometry identifies elevated histone H3 lysine 27 trimethylation in melanoma. Mol Cell Proteomics, 15(3), 765-75 (PMC4813699).
Byrum SD, Larson SK, Avaritt NL, Moreland LE, Mackintosh SG, Cheung W and Tackett AJ (2013) Quantitative Proteomics Identifies Activation of Hallmark Pathways of Cancer in Patient Melanoma. J Proteomics Bioinform, 6(3), 43-50 (PMC3748992).
Complete List of Published Work in MyBibliography (125 total publications)